MOLLIE DEAN: Open Payments
NPI 1578057535 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 55 payments from 15 companies in 2025. Trend: 2023 $773 · 2024 $767 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $208 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| Exact Sciences Corporation | 4 | $75 |
| Lilly USA, LLC | 3 | $62 |
| Amgen Inc. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 9 | $50 |
| Viatris Specialty LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Seqirus USA Inc | 1 | $27 |
Products named: Ozempic, FARXIGA, MOUNJARO, The Cologuard Plus Collection Kit, EVENITY, GEMTESA, VOQUEZNA, Wegovy.
Industry payments across AL — which companies pay providers there.
